Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Amal Waked"'
Autor:
Aria Leal de Sena, Alicy Evenlyn Paiva dos Santos, Amal Waked, Ana Julia Cintrão Pinheiro, Benedita Gabiella Pedroza Viana, Edivan Moraes Melo Junior, Elen Vinhote da Cunha, Luciana Taquita dos Anjos, Lucas Castro de Souza, Lucas Roberto Martins Binda, Maria Natacha Araújo Florêncio, Patrícia da Silva Chaves, Yamille Victória Silva Souza
Publikováno v:
VII ConCIFA-Congresso Científico FAMETRO: Ciência Inclusiva-2022 ISBN: 9786558662617
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f6fd31b99bf33590bd77dec71e0bfb4
https://doi.org/10.36229/978-65-5866-261-7.cap.28
https://doi.org/10.36229/978-65-5866-261-7.cap.28
Autor:
Amal Waked, Shlomo Birkenfeld, Z. Samuel, Yaron Niv, Rachel Hazazi, Alexander Vilkin, Eran Maoz, Moshe Leshno, Paul Rozen, Zohar Levi
Publikováno v:
Alimentary Pharmacology & Therapeutics. 31:523-533
Aliment Pharmacol Ther 31, 523–533 Summary Background Common reasons for elective screening and surveillance colonoscopy, at predetermined intervals, are family or personal history of colorectal cancer (CRC) or advanced adenoma (AAP). Quantified, h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b475297a413591a12d420dac6d4ee21
https://doi.org/10.1111/j.1365-2036.2009.04202.x
https://doi.org/10.1111/j.1365-2036.2009.04202.x
Autor:
Alexander Vilkin, Moshe Leshno, Zohar Levi, Paul Rozen, Yaron Niv, Rachel Hazazi, Eran Maoz, Shlomo Birkenfeld, Amal Waked
Publikováno v:
Alimentary Pharmacology & Therapeutics. 29:906-917
Faecal occult blood tests (FOBT) are faulted by low sensitivity for advanced adenomatous polyps (AAP). Quantified, immunochemical, haemoglobin (Hb)-specific immunochemical FOBT (I-FOBT) measurements are now used for colorectal screening.To correlate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65680289d4008fdecfaf2a84f293b27c
https://doi.org/10.1111/j.1365-2036.2009.03946.x
https://doi.org/10.1111/j.1365-2036.2009.03946.x
Autor:
Shlomo Birkenfeld, Amal Waked, Eran Maoz, Rachel Hazazi, Zohar Levi, S. Klang, Alex Vilkin, Nicky Lieberman, Paul Rozen, Yaron Niv
Publikováno v:
The American Journal of Gastroenterology. 104:933-938
We evaluated the effect of the use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDS), and anticoagulants on the performance of immunochemical fecal occult blood test (I-FOBT).A prospective, cross-sectional study of 1,221 ambulatory patients h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1faec70d93c83b378cb55bcd030829
https://doi.org/10.1038/ajg.2009.14
https://doi.org/10.1038/ajg.2009.14
Autor:
Yaron Rotman, Maya Cohen, Ziv Ben-Ari, Ran Tur-Kaspa, Jacklin Sulkes, Marisa Halpern, Marius Braun, Nir Barak, Hemda Schmilovitz-Weiss, Orit Pappo, Yaron Niv, Amal Waked
Publikováno v:
Journal of Clinical Gastroenterology. 42:408-412
BACKGROUND: The C-caffeine breath test (CBT) is a noninvasive tool for the evaluation of the cytochrome P450 system, implicated in the development of nonalcoholic steatohepatitis. GOAL: To apply the CBT to assess the extent of hepatic fibrosis in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f696b45698329eeee5d30fb05a0166d9
https://doi.org/10.1097/mcg.0b013e318046ea65
https://doi.org/10.1097/mcg.0b013e318046ea65
Publikováno v:
The American Journal of Gastroenterology. 100:2519-2525
OBJECTIVES: Guaiac fecal occult blood colorectal cancer (CRC) screening tests (FOBT) are faulted for low sensitivity and nonspecificity for human hemoglobin (Hb). Automated-developed, immunochemical, human Hb FOBT (I-FOBT) is specific, eliminates die
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86379c1bb47beacf50c9ae40b1ea06d6
https://doi.org/10.1111/j.1572-0241.2005.00231.x
https://doi.org/10.1111/j.1572-0241.2005.00231.x
Publikováno v:
Digestive diseases and sciences. 53(5)
Introduction In developing countries the recurrence rate of Helicobacter pylori after successful eradication therapy is as high as 42%, while in developed countries it is estimated to be less than 3%. Such figures are very important in terms of deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1e3512440a101441cab29298eb4306
https://pubmed.ncbi.nlm.nih.gov/18600454
https://pubmed.ncbi.nlm.nih.gov/18600454
Autor:
Zohar Levi, Rachel Hazazi, Amal Waked, Paul Rozen, Alexander Vilkin, Shlomo Birkenfeld, Eran Maoz, Yaron Niv
Publikováno v:
Alimentary pharmacologytherapeutics. 24(10)
SUMMARYBackgroundPatients at risk for non-syndromic (Lynch or polyposis) familial colorectalneoplasia undergo colonoscopic surveillance at intervals determined byclinically ascertained protocols. The quantitative immunochemical faecaloccult blood tes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afcc091b8129989bee135a328406402f
https://pubmed.ncbi.nlm.nih.gov/17032281
https://pubmed.ncbi.nlm.nih.gov/17032281
Publikováno v:
Alimentary pharmacologytherapeutics. 23(9)
Summary Background The sensitive guaiac faecal occult blood test, Haemoccult SENSA (HOS; Beckman Coulter, Fullerton, CA, USA), is our standard screening test for significant colorectal neoplasia. We evaluated an automatically-developed, quantified hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ef6fc1aea2a01e88da089963e8d61b
https://pubmed.ncbi.nlm.nih.gov/16629942
https://pubmed.ncbi.nlm.nih.gov/16629942
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 12(6)
The guaiac fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is user dependent and not specific for human hemoglobin (Hb). The automated-developed, quantitative, immunochemical human Hb FOBT (I-FOBT) is specific, allows for quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab43020b78562665d4e0f1727f11a035
https://pubmed.ncbi.nlm.nih.gov/16733493
https://pubmed.ncbi.nlm.nih.gov/16733493